These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7042845

  • 1. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
    Kobayashi Y, Asada M, Higuchi M, Osawa T.
    J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
    [Abstract] [Full Text] [Related]

  • 2. Human T cell hybridomas producing cytotoxic lymphokines: induction of lymphotoxin release and killer cell activity by anti-CD3 monoclonal antibody or lectins and phorbol ester.
    Ware CF, Green LM, Reade J, Stern ML, Berger AE.
    Lymphokine Res; 1986 Jun; 5(4):313-24. PubMed ID: 2878123
    [Abstract] [Full Text] [Related]

  • 3. Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.
    van Dongen JJ, Geurts van Kessel AH, Wolvers-Tettero IL, Versnel MA, van Oudenaren A, Schoenmaker E, Hagemeijer A.
    J Immunol; 1986 Aug 01; 137(3):1047-53. PubMed ID: 3487584
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors.
    Higuchi M, Asada M, Kobayashi Y, Osawa T.
    Cell Immunol; 1983 Jun 01; 78(2):257-65. PubMed ID: 6305517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Macrophage-chemotactic factor-producing T cell hybridomas reactive to phosphorylcholine in I-E-restricted manner.
    Harita S, Sugimura K, Watanabe T.
    Eur J Immunol; 1984 Aug 01; 14(8):692-7. PubMed ID: 6205880
    [Abstract] [Full Text] [Related]

  • 13. Lymphokine production by human T cell hybridomas.
    Le J, Vilcek J, Sadlik JR, Cheung MK, Balazs I, Sarngadharan MG, Prensky W.
    J Immunol; 1983 Mar 01; 130(3):1231-5. PubMed ID: 6401782
    [Abstract] [Full Text] [Related]

  • 14. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ, Morrissey DM, Oettgen HF, Old LJ.
    Fed Proc; 1984 Jun 01; 43(9):2465-9. PubMed ID: 6327400
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Establishment of a human T cell hybridoma cell line producing suppressor factor specific for anti-thyroglobulin antibody production.
    Noma T, Yata J.
    J Immunol; 1987 May 01; 138(9):2929-34. PubMed ID: 3494775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA, Farmer JL, Matzura CT, Hester RB, Rosenberg JS.
    J Immunol; 1984 Jan 01; 132(1):256-60. PubMed ID: 6361122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.